Evidence map›Paper›PMID 30074993›Full record

ArticlePloS one2018

Prevalence of newly detected diabetes in pregnancy in Qatar, using universal screening.

Mohammed Bashir, Manar E Abdel-Rahman, Mahmoud Aboulfotouh, Fatin Eltaher, Khalid Omar, Isaac Babarinsa, Kwabena Appiah-Sakyi, Tarek Sharaf, Eman Azzam, Mohammad Abukhalil and 6 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mohammed BashirQatar Metabolic Institute, Endocrine Department, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0003-3096-2641
Manar E Abdel-RahmanDepartment of Biostatistics, College of Health Sciences, Qatar University, Doha, Qatar.
Mahmoud AboulfotouhDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Fatin EltaherDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Khalid OmarDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Isaac BabarinsaDepartment of Obstetrics and Gynaecology, Sidra Medical and Research Centre-Doha, Qatar.
Kwabena Appiah-SakyiDepartment of Obstetrics and Gynaecology, Sidra Medical and Research Centre-Doha, Qatar.
Tarek SharafDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Eman AzzamDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Mohammad AbukhalilDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Malika BoumedjaneDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Wigdan YousifDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Warda AhmedDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Sadaf KhanDepartment of Obstetrics and Gynaecology, Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
Justin C KonjeDepartment of Obstetrics and Gynaecology, Sidra Medical and Research Centre-Doha, Qatar.
Abdul-Badi Abou-SamraQatar Metabolic Institute, Endocrine Department, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes first detected during pregnancy is currently divided into gestational diabetes mellitus (GDM) and diabetes mellitus (DM)- most of which are type 2 DM (T2DM). This study aims to define the prevalence and outcomes of diabetes first detected in pregnancy based on 75-gram oral glucose tolerance test (OGTT)using the recent WHO/IADPSG guidelines in a high-risk population.

methodsThis is a retrospective study that included all patients who underwent a 75 g (OGTT) between Jan 2016 and Apr 2016 and excluded patients with known pre-conception diabetes.

resultsThe overall prevalence of newly detected diabetes in pregnancy among the 2000 patients who fulfilled the inclusion/exclusion criteria was 24.0% (95% CI 22.1-25.9) of which T2DM was 2.5% (95% CI 1.9-3.3), and GDM was 21.5% (95% CI 19.7-23.3). The prevalence of newly detected diabetes in pregnancy was similar among the different ethnic groups. The T2DM group was older (mean age in years was 34 ±5.7 vs 31.7±5.7 vs 29.7 ±5.7, p<0.001); and has a higher mean BMI (32.4±6.4 kg/m2 vs 31.7±6.2 kg/m2 vs 29.7± 6.2 kg/m2, p< 0.01) than the GDM and the non-DM groups, respectively. The frequency of pre-eclampsia, pre-term delivery, Caesarean-section, macrosomia, LGA and neonatal ICU admissions were significantly higher in the T2DM group compared to GDM and non-DM groups.

conclusionDiabetes first detected in pregnancy is equally prevalent among the various ethnic groups residing in Qatar. Newly detected T2DM carries a higher risk of poor pregnancy outcomes; stressing the importance of proper classification of cases of newly detected diabetes in pregnancy.

Indexed as

AdultCross-Sectional StudiesDiabetes, GestationalDiabetes Mellitus, Type 2FemaleHumansMass ScreeningMiddle AgedPregnancyPregnancy in DiabeticsPrevalenceQatarRetrospective StudiesRisk FactorsYoung Adult

Identifiers

PMID30074993
PMCPMC6075760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.